Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 1;50(1):157-160.
doi: 10.1097/CCM.0000000000005153.

Chimeric Antigen Receptor T Cells, the Shock of the New

Affiliations
Editorial

Chimeric Antigen Receptor T Cells, the Shock of the New

Andrew Conway Morris. Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
    Gutierrez C, Brown ART, May HP, Beitinjaneh A, Stephens RS, Rajendram P, Nates JL, Pastores SM, Dharshan A, de Moraes AG, Hensley MK, Feng L, Brudno JN, Athale J, Ghosh M, Kochenderfer JN, Arias AS, Lin Y, McEvoy C, Mead E, Westin J, Kostelecky N, Mian A, Herr MM. Gutierrez C, et al. Crit Care Med. 2022 Jan 1;50(1):81-92. doi: 10.1097/CCM.0000000000005149. Crit Care Med. 2022. PMID: 34259446 Free PMC article.

References

    1. Hulvat MC. Cancer incidence and trends. Surg Clin North Am. 2020; 100:469–481
    1. Darmon M, Bourmaud A, Georges Q, et al. Changes in critically ill cancer patients’ short-term outcome over the last decades: Results of systematic review with meta-analysis on individual data. Intensive Care Med. 2019; 45:977–987
    1. Feins S, Kong W, Williams EF, et al. An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer. Am J Hematol. 2019; 94:S3–S9
    1. Gutierrez C, Brown ART, May HP, et al. Critically Ill Patients Treated for Chimeric Antigen Receptor–Related Toxicity: A Multicenter Study. Crit Care Med. 2022; 50:81–92
    1. Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. Blood Rev. 2019; 34:45–55

Substances

LinkOut - more resources